Safety of Contrast in Stress Echocardiography in Stable Patients and in Patients With Suspected Acute Coronary Syndrome but Negative 12-Hour Troponin

American Journal of Cardiology

Volumn 104, Issue 1, 2009, Pages 14-18

  Anantharam, Brijesh ^a   Chahal, Navtej ^a   Chelliah, Rajesh ^a   Ramzy, Ihab ^a   Gani, Firoz ^a   Senior, Roxy ^a  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; ATROPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DOBUTAMINE; PERFLUTREN; SONOVUE; TROPONIN;

ACUTE CORONARY SYNDROME; ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; COMPLETE HEART BLOCK; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DOBUTAMINE STRESS ECHOCARDIOGRAPHY; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG SAFETY; ELECTROCARDIOGRAM; EXERCISE STRESS ECHOCARDIOGRAPHY; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART LEFT VENTRICLE FUNCTION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTENSION; HYPOTENSION; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; SHIVERING; STABLE ANGINA PECTORIS; STRESS ECHOCARDIOGRAPHY; SUPRAVENTRICULAR TACHYCARDIA;

ACUTE CORONARY SYNDROME; AGED; CHEST PAIN; CONTRAST MEDIA; ECHOCARDIOGRAPHY, STRESS; FEMALE; HEMODYNAMICS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TROPONIN;

EID: 62449253549     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.02.041     Document Type: Article

References (22)

1. Schiller N.B., Shah P.M., Crawford M., DeMaria A., Devereux R., Feigenbaum H., Gutgesell H., Reichek N., Sahn D., Schnittger I., Silverman A.H., Tajik A.J., American Society of Echocardiography Committee on Standards, and Subcommittee on Quantitation of Two-Dimensional Echocardiograms. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 2 (1989) 358-367
2. Thanigaraj S., Nease Jr. R.F., Schechtman K.B., Wade R.L., Loslo S., and Pérez J.E. Use of contrast for image enhancement during stress echocardiography is cost-effective and reduces additional diagnostic testing. Am J Cardiol 87 (2001) 1430-1432
3. Hoffmann R., Marwick T.H., Poldermans D., Lethen H., Ciani R., van der Meer P., Tries H.P., Gianfagna P., Fioretti P., Bax J.J., Katz M.A., Erbel R., and Hanrath P. Refinements in stress echocardiographic techniques improves interinstitutional agreement in interpretation of dobutamine stress echocardiograms. Eur Heart J 23 (2002) 821-829
4. Yong Y., Wu D., Fernandes V., Kopelen H.A., Shimoni S., Nagueh S.F., Callahan J.D., Bruns D.E., Shaw L.J., Quinones M.A., and Zoghbi W.A. Diagnostic accuracy and cost-effectiveness of contrast echocardiography on evaluation of cardiac function in technically very difficult patient in the intensive care unit. Am J Cardiol 89 (2002) 711-718
5. Ikonomidis I., Holmes E., Narbuvold H., Bolstad B., Muan B., and Nihoyannopoulos P. Left ventricular wall motion assessment and endocardial border delineation after intravenous injection of Infoson™ during dobutamine stress echocardiography. Coron Artery Dis 9 (1998) 567-576
6. Rainbird A.J., Mulvagh S.L., Oh J.K., McCully R.B., Klarich K.W., Shub C., Mahoney D.W., and Pellikka P.A. Contrast dobutamine stress echocardiography clinical practice assessment in 300 consecutive patients. J Am Soc Echocardiogr 14 (2001) 375-378
7. Varga A., Garcia M.A., and Picano E. Safety of stress echocardiography (from the International Stress Echo Complication Registry). Am J Cardiol 98 (2006) 541-543
8. Mathias W., Arruda A., Santos F.C., Arruda A.L., Mattos E., Osório A., Campos O., Gil M., Andrade J.L., and Carvalho A.C. Safety of dobutamine-atropine stress echocardiography: a prospective experience of 4033 consecutive studies. J Am Soc Echocardiogr 12 (1999) 785-791
9. Secknus M.A., and Marwick T.H. Evolution of dobutamine echocardiography protocols and indications: safety and side effects in 3,011 studies over 5 years. J Am Coll Cardiol 29 (1997) 1234-1240
10. Timperley J., Mitchell A.R., Thibault H., Mirza I.H., and Becher H. Safety of contrast dobutamine stress echocardiography: a single center experience. J Am Soc Echocardiogr 18 (2005) 163-167
11. Tsutsui J.M., Elhendy A., Xie F., O'Leary E.L., McGrain A.C., and Porter T.R. Safety of dobutamine stress real-time myocardial contrast echocardiography. J Am Coll Cardiol 45 (2005) 1235-1242
12. Aggeli C., Giannopoulos G., Roussakis G., Christoforatou E., Marinos G., Toli C., Pitsavos C., and Stefanadis C. Safety of myocardial flash-contrast echocardiography in combination with dobutamine stress testing for detection of ischemia in 5250 studies. Heart 94 (2008) 1571-1577
13. Cerqueira M.D., Weissman N.J., Dilsizian V., Jacobs A.K., Kaul S., Laskey W.K., Pennell D.J., Rumberger J.A., Ryan T., and Verani M.S. Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: a statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. Circulation 105 (2002) 539-542
14. McCully R.B., Roger V.L., Mahoney D.W., Karon B.L., Oh J.K., Miller Jr. F.A., Seward J.B., and Pellikka P.A. Outcome after normal exercise echocardiography and predictors of subsequent cardiac events: follow-up of 1,325 patients. J Am Coll Cardiol 31 (1998) 144-149
15. Gabriel R.S., Smyth Y.M., Menon V., Klein A.L., Grimm R.A., Thomas J.D., and Sabik E.M. Safety of ultrasound contrast agents in stress echocardiography. Am J Cardiol 102 (2008) 1269-1272
16. Shaikh K., Chang S.M., Peterson L., Rosendahl-Garcia K., Quinones M.A., Nagueh S.F., Kurrelmeyer K., and Zoghbi W.A. Safety of contrast administration for endocardial enhancement during stress echocardiography compared with noncontrast stress. Am J Cardiol 102 (2008) 1444-1450
17. Weidmann B., Lepique C.U., Jansen W., Stoiber W.U., and Tauchert M.O. Myocardial infarction as a complication of dobutamine stress echocardiography. J Am Soc Echocardiogr 10 (1997) 768-771
18. Vancraeynest D., Kefer J., Hanet C., Fillee C., Beauloye C., Pasquet A., Gerber B.L., Philippe M., and Vanoverschelde J.L. Release of cardiac bio-markers during high mechanical index contrast-enhanced echocardiography in humans. Eur Heart J 28 (2007) 1236-1241
19. Fisher N.G., Christiansen J.P., Klibanov A., Taylor R.P., Kaul S., and Lindner J.R. Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement. J Am Coll Cardiol 40 (2002) 811-819
20. Nucifora G., Marsan N.A., Siebelink H.M., van Werkhoven J.M., Schuijf J.D., Schalij M.J., Poldermans D., Holman E.R., and Bax J.J. The safety of contrast-enhanced echocardiography within 24 hours after myocardial infarction. Eur J Echocardiogr 9 (2008) 816-818
21. Plana J.C., Mikati I.A., Dokainish H., Lakkis N., Abukhalil J., Davis R., Hetzell B.C., and Zoghbi W.A. A randomized cross-over study for evaluation of the effect of image optimization with contrast on the diagnostic accuracy of dobutamine echocardiography in coronary artery disease: the OPTIMIZE trial. J Am Coll Cardiol Img 1 (2008) 145-152
22. Dolan M.S., Gala S.S., Dodla S., Abdelmoneim S.S., Xie F., Cloutier D., Bierig M., Mulvagh S.L., Porter T.R., and Labovitz A.J. Safety and efficacy of commercially available ultrasound contrast agents for rest and stress echocardiography a multicenter experience. J Am Coll Cardiol 53 (2009) 32-38